Bottom line
What is MDODX's expense ratio?
MDODX's expense ratio is 1.11%, or about $111 a year on every $10,000 invested. That is more expensive than 69% of international stock funds we track (median 0.9%). It has no front-end sales load.
Updated Apr 30, 2026
MDODX fee table
| Net expense ratio | 1.11% |
|---|---|
| Gross expense ratio | 21.74% |
| Management fee | 0.9% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 20.84% |
| Fee waiver / reimbursement | 20.63% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | -2% |
Source: Fund prospectus fee table, filed Apr 30, 2026
What MDODX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MDODX | $113 | $3,906 | $6,535 | $10,099 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.11% expense ratio costs roughly $60,900 in lost growth, versus about $50,300 for the median international stock fund (0.9%).